Silo Pharma, Inc.
SILO
$0.6283
-$0.0108-1.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | 0.00% | 0.00% | 7.14% | 0.00% | 0.00% |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | -12.55% | -10.57% | -10.58% | -17.29% | -37.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.08% | 23.91% | 54.97% | 29.91% | -9.90% |
| Operating Income | -24.51% | -24.40% | -55.83% | -30.61% | 10.06% |
| Income Before Tax | -29.24% | -28.65% | -64.57% | -40.68% | 8.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.24% | -28.65% | -64.57% | -40.68% | 8.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.24% | -28.65% | -54.35% | -40.68% | 8.02% |
| EBIT | -24.51% | -24.40% | -55.83% | -30.61% | 10.06% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 37.16% | 17.74% | -1.37% | -1.65% | 4.98% |
| Normalized Basic EPS | 37.01% | 17.51% | -7.74% | -1.97% | 4.56% |
| EPS Diluted | 37.16% | 17.74% | -1.37% | -1.65% | 4.98% |
| Normalized Diluted EPS | 37.01% | 17.51% | -7.74% | -1.97% | 4.56% |
| Average Basic Shares Outstanding | 105.71% | 56.42% | 45.79% | 38.37% | -3.21% |
| Average Diluted Shares Outstanding | 105.71% | 56.42% | 45.79% | 38.37% | -3.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |